Key facts
| Price (PPV) | 46.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | mometasone |
| Class | Nasal preparations |
| ATC code | R01AD09 |
| Manufacturer | MAPHAR |
| Presentation | Flacon de 40 doses |
| Hospital price | 29.20 MAD |
| Data collected on | 9/8/2026 |
Indications
La mometason est indiquée chez les adultes et les enfants à partir de 3 ans en traitement symptomatique de la rhinite allergique saisonnière ou de la rhinite perannuelle. En pulvérisation nasale elle est aussi est indiquée dans le traitement de la polypose nasale chez les adultes à partir de 18 ans.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Metanaz 50 µg (CIPLA MAROC) contains the same active substance as NASONEX 50 µg / dose (Mometasone) at the same strength, but in a different pack: Flacon de 140 doses at 102.80 MAD, i.e. 0.73 MAD per unit against 1.17 MAD for NASONEX 50 µg / dose. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Metanaz 50 µg | CIPLA MAROC | Flacon de 140 doses | 102.80 MAD | 0.73 / unit |
| Risonel 50 µg | BOTTU S.A. | 140 doses | 111.30 MAD | 0.79 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About NASONEX 50 µg / dose
NASONEX 50 µg / dose belongs to the nasal preparations therapeutic class. In Morocco, this drug is marketed by MAPHAR and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of NASONEX 50 µg / dose, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about NASONEX 50 µg / dose
Answers to common questions from Moroccan patients about this drug.